Century Share Price

Century Share Price

NASDAQ: IPSC | Micro Cap | Healthcare
$1.36
+0.00 (0.00%) Last updated on 19 Nov, 2026 | 01:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Century Stock Performance

Open
$1.36
Prev. Close
$1.36
Circuit Range
N/A
Day Range
$1.33 - $1.46
Year Range
$0.45 - $3.04
Volume
82,571
Average Traded
$1.41

Century Share Price Today

As of 19 November 2026, Century Therapeutics, Inc.'s share price is $1.36. The stock opened at $1.36, compared to its previous close of $1.36. During today's trading session, Century Therapeutics, Inc.'s share price traded between $1.33 and $1.46, with an average price of $1.40. Over the past 52 weeks, the stock has recorded a high of $3.04 and a low of $0.45. In terms of performance, Century Therapeutics, Inc.'s share price has declined by 44.17% over the last six months and is up 150.00% on a year-on-year basis.

Century Share Price Chart

Line chart of the Century price trend over the selected period. The price rose overall, ranging from 1.33 to 1.46, ending at 1.36.
$1.33$1.46
L
Show Current Price
H

Century Stock Fundamentals & Key Indicators

Market Cap
$118.15M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.54
Revenue (TTM)
$109.16B
Return On Equity (TTM)
-47.06%
Profit Margin
-8.78%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-22.33%

Century Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$19.17-$21.65-$34.55-$23.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-12.94%-59.58%32.13%

Century Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$5.20$2.24$6.59$109.16
Net Profit-$130.93-$136.67-$126.57-$9.58
Net Profit Margin-2517.88%-6101.34%-1920.64%-8.78%
Income ChangeN/A-4.38%7.39%92.43%

Century Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets102.94159.17183.7166.82
Current Assets120.77194.05176.99319.72
Total Assets223.7353.22360.69486.54
Non Current Liabilities44.5462.07158.1153.99
Current Liabilities20.23129.7817.8529.82
Total Liabilities64.77191.85175.94183.81
Shareholders' Equity158.94161.36184.75302.74

Century Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-103.88-110.14-88.3514.05
Investing107.547.4861.13-13.13
Financing0.1774.56-9.7327.16

About Century

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Century Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.47
$1.36
-8.39%
Oct 2026
$1.67
$1.49
-12.61%
Sep 2026
$2.00
$1.71
-23.54%
Aug 2026
$2.01
$2.23
+10.12%
Jul 2026
$2.44
$2.02
-17.35%
Jun 2026
$2.43
$2.45
+0.20%
May 2026
$2.33
$2.44
+6.77%
Apr 2026
$2.32
$2.29
+1.33%
Mar 2026
$2.27
$2.26
-2.59%
Feb 2026
$1.88
$2.32
+21.78%
Jan 2026
$1.03
$1.91
+95.18%
Dec 2025
$0.54
$0.98
+78.75%

Century Share Price FAQs